Literature DB >> 2579248

Cloning and nucleotide sequences of cDNAs spanning the splice junctions of Rous sarcoma virus mRNAs.

L J Chang, C M Stoltzfus.   

Abstract

The cDNAs corresponding to the 5' ends of the mRNAs coding for the envelope protein precursor (gPr92env) of the B77 strain and the transforming protein (pp60src) of the Prague B strain of Rous sarcoma virus were cloned into pBR322, and the nucleotide sequences surrounding the splice junctions were determined. Both mRNAs are products of single splicing events from a common donor splice site at nucleotide 398 from the 5' end of the RNA to acceptor splice sites at nucleotides 5078 and 7054 for the env and src mRNAs, respectively. These results confirm and extend previous conclusions based on peptide mapping and single-strand nuclease mapping. Compared with the sequence of the Prague C genome RNA, the B77 strain contains a 6-nucleotide deletion in the sequence corresponding to the hydrophobic portion of the signal peptide of the envelope protein precursor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579248      PMCID: PMC254734     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  In vitro, the major ribosome binding site on Rous sarcoma virus RNA does not contain the nucleotide sequence coding for the N-terminal amino acids of the gag gene product.

Authors:  J L Darlix; P F Spahr; P A Bromley; J C Jaton
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

2.  A bacterial clone synthesizing proinsulin.

Authors:  L Villa-Komaroff; A Efstratiadis; S Broome; P Lomedico; R Tizard; S P Naber; W L Chick; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  Nucleotide sequence of Rous sarcoma virus.

Authors:  D E Schwartz; R Tizard; W Gilbert
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

4.  The leader sequence of the subgenomic mRNA's of Rous sarcoma virus is approximately 390 nucleotides.

Authors:  P B Hackett; R Swanstrom; H E Varmus; J M Bishop
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

5.  Nucleotide sequence of the 5' noncoding region and part of the gag gene of Rous sarcoma virus.

Authors:  R Swanstrom; H E Varmus; J M Bishop
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

6.  Nucleotide sequence of noncoding regions in Rous-associated virus-2: comparisons delineate conserved regions important in replication and oncogenesis.

Authors:  D Bizub; R A Katz; A M Skalka
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

7.  Avian sarcoma virus gag and env gene structural protein precursors contain a common amino-terminal sequence.

Authors:  T A Ficht; L J Chang; C M Stoltzfus
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

8.  Complete sequence of the Rous sarcoma virus env gene: identification of structural and functional regions of its product.

Authors:  E Hunter; E Hill; M Hardwick; A Bhown; D E Schwartz; R Tizard
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

9.  Transduction of a cellular oncogene: the genesis of Rous sarcoma virus.

Authors:  R Swanstrom; R C Parker; H E Varmus; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

Review 10.  Comparison of initiation of protein synthesis in procaryotes, eucaryotes, and organelles.

Authors:  M Kozak
Journal:  Microbiol Rev       Date:  1983-03
View more
  15 in total

1.  Two distant upstream regions containing cis-acting signals regulating splicing facilitate 3'-end processing of avian sarcoma virus RNA.

Authors:  J T Miller; C M Stoltzfus
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Mutations in the regions of the Rous sarcoma virus 3' splice sites: implications for regulation of alternative splicing.

Authors:  S L Berberich; C M Stoltzfus
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Comparison of Rous sarcoma virus RNA processing in chicken and mouse fibroblasts: evidence for double-spliced RNA in nonpermissive mouse cells.

Authors:  S L Berberich; M Macias; L Zhang; L P Turek; C M Stoltzfus
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesis in vitro.

Authors:  E Bieth; C Gabus; J L Darlix
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

5.  Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect the accumulation of unspliced RNA.

Authors:  C M Stoltzfus; S J Fogarty
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

6.  In vitro expression of two proteins from overlapping reading frames in a eukaryotic DNA sequence.

Authors:  J M Jankowski; S A Krawetz; E Walczyk; G H Dixon
Journal:  J Mol Evol       Date:  1986       Impact factor: 2.395

7.  Efficient transformation by Prague A Rous sarcoma virus plasmid DNA requires the presence of cis-acting regions within the gag gene.

Authors:  C M Stoltzfus; L J Chang; T P Cripe; L P Turek
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

8.  A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging.

Authors:  R A Katz; R W Terry; A M Skalka
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

9.  Gene expression from both intronless and intron-containing Rous sarcoma virus clones is specifically inhibited by anti-sense RNA.

Authors:  L J Chang; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

10.  A base-paired structure in the avian sarcoma virus 5' leader is required for efficient encapsidation of RNA.

Authors:  J B Knight; Z H Si; C M Stoltzfus
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.